Arcus Capital Partners’s iBio IBIO Stock Holding History

Arcus Capital Partners’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-88	Closed	-$46K	–	115
2021 Q3	$46K	Hold	88	–	–	0.02%	98
2021 Q2	$66K	Hold	88	–	–	0.03%	104
2021 Q1	$68K	Hold	88	–	–	0.01%	109
2020 Q4	$46K	Buy	+88	New	+$71.7K	0.01%	108
2017 Q2	–	Sell	-621	Closed	-$1.34M	–	106
2017 Q1	$1.34M	Hold	621	–	–	0.84%	19
2016 Q4	$1.23M	Hold	621	–	–	0.83%	18
2016 Q3	$1.71M	Buy	+621	New	+$1.95M	1.25%	10
2016 Q2	–	Sell	-201	Closed	-$569K	–	67
2016 Q1	$569K	Hold	201	–	–	0.41%	32
2015 Q4	$563K	Buy	+201	New	+$641K	0.41%	33

Other funds holding IBIO

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return